| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 324,944 | 341,737 | 333,566 | 455,821 | | Cost of Revenue | 251,396 | 241,540 | 249,083 | 323,113 | | | Gross Profit | 73,548 | 100,197 | 84,483 | 132,708 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 83,222 | 83,854 | 83,606 | 89,969 | | Non Recurring | 1,174 | 465 | 1,186 | 600 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,848) | 15,878 | (309) | 42,139 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 76 |
-
| 12 | | Earnings Before Interest And Taxes | (14,302) | 15,954 | (309) | 42,151 | | Interest Expense | (2,375) | 1,217 | 1,158 | 1,341 | | Income Before Tax | (11,927) | 14,737 | (1,467) | 40,810 | | Income Tax Expense | (4,608) | 5,644 | (562) | 15,475 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,319) | 9,093 | (905) | 25,335 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,319) | 9,093 | (905) | 25,335 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,319) | $9,093 | ($905) | $25,335 |
|
1.52% Nasdaq 
Income Statement
